Esta traducción se está preparando. Mientras tanto, mostramos temporalmente la versión original en inglés.
Negocios · 2/2/20011 min de lectura
John J. Ferrante et al; Withdrawal of Approval of 125 Abbreviated New Drug Applications
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA) is withdrawing approval of 125 abbreviated new drug applications (ANDA's). The basis for the withdrawals is that the holders of the applications have repeatedly failed to file required annual reports for these applications.
Idioma original de la fuente: Federal Register — Food and Drug AdministrationAbrir el comunicado original →